Suppr超能文献

对具有抗锥虫功效的来自Tabebuia的萘醌进行化学反应性研究。

Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy.

作者信息

Pinto C N, Dantas A P, De Moura K C, Emery F S, Polequevitch P F, Pinto M C, de Castro S L, Pinto A V

机构信息

Núcleo de Pesquisas em Produtos Naturais, Centro de Ciências da Saúde, Universidade Federal, Rio de Janeiro, Brazil.

出版信息

Arzneimittelforschung. 2000 Dec;50(12):1120-8. doi: 10.1055/s-0031-1300337.

Abstract

The biological activities of the naphthoquinones lapachol and its cyclization product beta-lapachone, extracted from trees of the genus Tabebuia, have been intensively studied. Given continuity to the studies about heterocyclic derivatives obtained from the reaction of these naphtoquinones with amino-containing reagents, 22 derivatives of beta-lapachone, nor-beta-lapachone and lapachol were synthesised and their activities against trypomastigote forms of T. cruzi were evaluated. The compounds were grouped as oxazolic, imidazolic, phenoxazinic, indolic, pyranic and cyclopentenic derivatives. The variability of the new structures is based on the great electrophilicity of 1,2-quinoidal carbonyls towards reagents containing nitrogen or carbon as nucleophilic centres. In relation to the trypanocidal activity of the synthesised compounds, in view of their structural diversity, tendencies only could be verified. Among the cyclofunctionalised products the oxazolic and imidazolic derivatives showed +/- 1.5 to 34.8 times higher activity than crystal violet, the standard drug for the sterilization of stored blood. These results corroborate the tendency of trypanocidal activity in imidazolic skeletons, and indicate that this moiety could be used as a guide for architectural delineation of molecules with potential value for the chemotherapy of Chagas disease.

摘要

从Tabebuia属树木中提取的萘醌类化合物拉帕醇及其环化产物β-拉帕醌的生物活性已得到深入研究。为了延续对这些萘醌与含氨基试剂反应所得杂环衍生物的研究,合成了22种β-拉帕醌、去甲-β-拉帕醌和拉帕醇的衍生物,并评估了它们对克氏锥虫无鞭毛体形式的活性。这些化合物被归类为恶唑类、咪唑类、吩恶嗪类、吲哚类、吡喃类和环戊烯类衍生物。新结构的多样性基于1,2-醌型羰基对以氮或碳为亲核中心的试剂具有很强的亲电性。鉴于合成化合物的结构多样性,仅能验证其杀锥虫活性的趋势。在环官能化产物中,恶唑类和咪唑类衍生物的活性比用于储存血液灭菌的标准药物结晶紫高1.5至34.8倍。这些结果证实了咪唑类骨架具有杀锥虫活性的趋势,并表明该部分可作为指导分子结构设计的依据,这些分子对恰加斯病化疗具有潜在价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验